Mark G. Eller

Mark G. Eller possesses extensive experience in the pharmaceutical industry, currently serving as the Managing Member at Eller Pharma Consulting, LLC since April 2017, where assistance is provided to startups and colleagues on special projects. Other significant roles include Member at OccamPoint since 2019, and Senior Vice President of R&D at Aria Pharmaceuticals from November 2018 to February 2023. Mark G. Eller has held various senior positions at Jazz Pharmaceuticals, Quintiles, Hoechst Marion Roussel, Marion Merrell Dow, and The Upjohn Company, demonstrating a progressive career trajectory in research and development, clinical pharmacology, and drug development. Educational qualifications include a Ph.D. in Pharmaceutics/Pharmacokinetics and a B.S. in Pharmacy from the University of Iowa.